Single-dose therapeutic interfering particle lowers SARS-CoV-2 pathogenesis and shedding among hamsters

Researchers reported that a single-dose therapeutic interfering particle (TIP) lowers SARS-CoV-2 pathogenesis and shedding among hamsters.

Immunological perspectives on the pathogenesis, diagnosis, prevention and treatment of COVID-19

A rational roadmap for SARS‐CoV‐2/COVID‐19 pharmacotherapeutic research and development: IUPHAR Review 29 - Alexander - 2020 - British Journal of Pharmacology - Wiley Online Library

Recent advances in developing small-molecule inhibitors against SARS-CoV-2 - ScienceDirect

Live-attenuated YF17D-vectored COVID-19 vaccine protects from lethal yellow fever virus infection in mouse and hamster models - eBioMedicine

IJMS, Free Full-Text

A single-administration therapeutic interfering particle reduces SARS-CoV-2 viral shedding and pathogenesis in hamsters. - Abstract - Europe PMC

Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms

Identification of a therapeutic interfering particle—A single-dose SARS-CoV- 2 antiviral intervention with a high barrier to resistance - ScienceDirect

Hamster models of COVID-19 pneumonia reviewed: How human can they be? - Achim D. Gruber, Theresa C. Firsching, Jakob Trimpert, Kristina Dietert, 2022